Jun 4, 2023
Two-Drug Combo Wins for Refractory Gout
MILAN — About half of patients receiving infusions of a novel uricase analog, along with a proprietary rapamycin formulation, in two similarly designed phase III studies got their serum urate under control, after multiple other medications had failed to do so, a researcher said here. Dubbed SEL-212, the treatment combines a pegylated form of uricase called pegadricase with “an immune-tolerizing…
View On WordPress